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Background: Non-palpable thyroid nodules can be difficult to access by conventional ultrasound-guided fine
needle aspiration, particularly when they are intrathoracic. Many of these patients are subject to multiple follow up
scans or invasive diagnostic procedures such as mediastinoscopy or surgical resection. We aim to describe the
feasibility of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for diagnosis of
thyroid lesions.
Methods: All EBUS-TBNA performed at our institutions from February 2010 to February 2013 were screened, and
those in which a thyroid biopsy was performed were reviewed.
Results: We identified 12 cases of EBUS-TBNA thyroid biopsy. Nine patients had an indication for EBUS in addition
to their thyroid lesions. The median age was 64 years (range 44 to 84 years), and 10 patients were male. Median
lesion size was 22.5 mm (range, 10 to 43 mm). Five lesions were strictly intrathoracic. All cases were sampled with a
22G needle and rapid on-site cytologic examination. Adequate samples were obtained in all 12 cases. Malignancy
was identified in 3 of the 12 patients (metastatic breast adenocarcinoma, large B-cell lymphoma, and metastatic
lung adenocarcinoma). The remaining 9 samples were deemed to be benign nodules. Seven of these were
confirmed by clinical follow-up (n = 3), biopsies (n = 3), or surgery (n = 1).
There were no EBUS-related complications.
Conclusions: EBUS-TBNA might be a safe and effective alternative for sampling thyroid lesions, particularly useful
for those located below the thoracic inlet. Further prospective studies are required to compare its diagnostic yield
and safety profile with standard techniques.
Keywords: EBUS-TBNA, Thyroid, Intrathoracic goiterBackground
Thyroid nodules occur in about 5-7% of the population,
and of those, about 5% turn out to be malignant. Malig-
nancy can be diagnosed through ultrasound-guided fine
needle aspiration (US- FNA) with a low rate of compli-
cations and adequate samples for diagnosis in about 80%
of cases, making it the procedure of choice [1-3]. Never-
theless, access to lesions that lie near the thoracic inlet* Correspondence: casal@bcm.edu
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unless otherwise stated.or within the thoracic cavity can be difficult, risky, or
even impossible with US- FNA. These cases typically
lead to multiple follow up images or more invasive
diagnostic modalities such as mediastinoscopy or surgical
excision.
Endobronchial ultrasound-guided transbronchial nee-
dle aspiration (EBUS-TBNA) is now a well- established
technique for sampling peribronchial and paratracheal
lymph nodes and masses [4,5]. It plays a key role in
mediastinal staging of lung cancer with comparable and
even superior diagnostic yield than mediastinoscopy,
and with an excellent safety profile [6-8]. Literature re-
view reveals only a few case reports of EBUS-TBNA fortd. This is an Open Access article distributed under the terms of the Creative
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aim of this study is to describe our experience of EBUS-
TBNA for the sampling of thyroid lesions in terms of
feasibility, diagnostic yield and safety profile.
Methods
After obtaining IRB approval, medical records from all
EBUS-TBNA procedures performed on patients older
than 18 years of age at the Michael E. DeBakey VA
Medical Center (Houston, Texas) and at the New York
Methodist Hospital (Brooklyn, New York) from February
2010 to February 2013 were reviewed. Due to the retro-
spective nature of the study, patient consent was waived
by our local IRB (Institutional Review Board). We
retrieved and analyzed those cases in which a thyroid
biopsy was performed with EBUS-TBNA. Demographic
and clinical data were obtained, including: baseline thyroid
disease, size and location of thyroid lesion, indications for
bronchoscopy, pre-procedure diagnoses, imaging reports
prior to bronchoscopy and up to 12 months afterwards
when available, description of techniques used in acquir-
ing and processing the biopsy, documented complications
of biopsy acquisition, pathology reports, and clinical
reports up to 12 months after EBUS-TBNA. The result
provided by EBUS-TBNA biopsy was compared to that of
surgically removed thyroid specimens or US-FNA when
available. Otherwise, the patient’s clinical course and
follow up images for up to 12 months were examined to
determine if there was a correlation with the original
diagnosis.
Results
We identified 12 cases of EBUS-TBNA thyroid biopsy.
In 9 patients, the primary indication for EBUS-TBNA
was sampling of mediastinal lymph nodes or masses,
and biopsy of the thyroid was done in addition to this
during the same procedure. In the remainder 3, biopsy
of an intrathoracic thyroid lesion was the only indication
for EBUS-TBNA. Eleven patients underwent the proced-
ure via laryngeal mask airway under general anesthesia
and one under moderate sedation via oropharynx. In all
cases biopsies were performed using a real-time ultra-
sound biopsy bronchoscope (XBF-UC260F-OL8; Olympus
Ltd.; Tokyo, Japan) in standard fashion. Only in one pro-
cedure the operator reported difficulty introducing the
needle through the tracheal wall due to the acute angle
necessary to reach the lesion. Samples were obtained
with a dedicated 22-gauge needle (NA-201SX; Olympus
Ltd.; Tokyo, Japan), with an average of 4 passes. On-site
cytology examination was available in all procedures.
Needle aspirates were smeared onto slides and air-dried
or fixed in 95% alcohol, collecting the remaining aspirate
for cell-block preparation. Slides were processed immedi-
ately using Romanowsky technique (Diff- Quik®) and/orPap- staining. The characteristics of each patient are
summarized in Table 1. The median age was 64 years
(range 44 to 84 years), and 10 patients (83%) were male.
Median lesion size in the short axis was 22.5 mm (range,
10 to 43 mm). Eleven lesions (92%) were on the left thy-
roid lobe and one on the right. Five lesions (42%) were
strictly intrathoracic. Adequate samples were obtained in
all 12 cases (see examples in Figure 1). Malignancy was
identified in 3 (25%) patients: metastatic adenocarcinoma
of the breast, large B-cell lymphoma, and metastatic
adenocarcinoma of lung origin. There was thyroid tissue
in the background of these biopsies confirming thyroid
sampling. These were de novo diagnosis of malignancy
for each patient. The remaining 9 samples were deemed
to be benign lesions (follicular nodules = 8, multinodular
goiter = 1,). Seven of these 9 benign diagnoses were
confirmed by clinical-radiographic follow-up (n = 3), CT-
guided or US-FNA (n = 3), or surgery (n = 1). Based on
the clinical and radiographical (i.e. radionuclide scanning,
follow-up ultrasound) behavior of these lesions, they were
all presumed to be benign. The diagnosis of multinodular
goiter was made with histopathology from surgical resec-
tion. There were no EBUS-related complications. Of note,
one of the patients who underwent a subsequent US-
FNA developed a large hematoma as a complication of
the procedure.
Discussion
Ultrasound-guided FNA is the procedure of choice for
sampling of thyroid nodules [12]. Nevertheless, for those
lesions located below the thoracic inlet, the procedure
becomes challenging and it imposes a higher risk since
the needle trajectory is close to many vital structures.
Our case series demonstrates that EBUS-TBNA is a feas-
ible diagnostic approach for these lesions, being poten-
tially safe and effective as well.
As previously mentioned, US-FNA provides diagnos-
tically useful information in about 80% of thyroid nod-
ules and has an average sensitivity of about 95% in
patients with malignant thyroid nodules [13]. In our lim-
ited experience, EBUS-TBNA has provided cytologic
samples comparable to those of US-FNA. Moreover, the
EBUS scope also allowed us to characterize the gland and
lesion in question providing ultrasonographic characteris-
tics that can predict malignancy: solid mass, microcal-
cifications, increased vascularity, irregular borders [3].
Nevertheless, the authors could not over emphasize the
fact that the decision to sample any thyroid lesion should
always be made together with the managing endocrinolo-
gist. The diagnostic work up of the thyroid nodule has
been extensively reviewed elsewhere in the literature and
it is not within the scope of our manuscript [1,3,13,14].
Our malignancy rate was much higher (3/12, 25%)
than that expected for thyroid nodules in the general
Table 1 Patient characteristics
Subject Baseline thyroid disease Indication for procedure Size (mm)** Strictly intrathoracic Diagnosis
1 Multinodular goiter Multiple lung masses, enlarged
mediastinal LNs
19 No Follicular nodule
2 None Lung mass w/ enlarged hilar LNs 26 No Large B-cell lymphoma
3 None Lung mass 20 No Follicular nodule
4* None Enlarged mediastinal LNs 20 Yes Metastatic breast
adenocarcinoma
5 None Superior mediastinal mass 25 Yes Follicular nodule
6 None Lung mass 18 No Follicular nodule
7 Subclinical hypothyroidism Lung mass 33 Yes Follicular nodule
8 Subclinical hyperthyroidism Enlarged mediastinal LNs 32 Yes Follicular nodule
9 None Lung mass, enlarged mediastinal LNs 10 No Metastatic lung
adenocarcinoma
10 None Lung mass w/ enlarged hilar LNs 33 No Follicular nodule
11 None Substernal thyroid mass 44 No Follicular nodule
12* None Incidentally found anterior mediastinal
mass
16 Yes Multinodular goiter
*Patients number 4 and 12 were the only female in this study.
**Measured in the short axis.
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static to the thyroid, and none were primary thyroid
neoplasms. We, indeed, found the most common non-
thyroid malignancies that involve the thyroid: lym-
phoma, breast cancer, and lung cancer. This is likely
because our population was referred for EBUS-TBNA of
mediastinal lymph nodes or masses, hence with a much
higher pre-test probability of having a malignancy out-
side the thyroid. The need to sample the thyroid, inFigure 1 Representative microphotographs from EBUS-guided thyroid
(A) papanicoulau stained smear and (B) cell block showing a poorly differe
showed these tumor cells with strong and diffuse positivity for TTF1 (C), fo
for CK7 (E), and strong diffuse positivity for pancytokeratin. (G) and (H) sho
and colloid. (I) Cell block preparation showing thyroid follicles with colloidaddition to their lung or mediastinal lesions, was to rule
out a second primary cancer. Four of our patients had
an incidental finding of an 18-fluorodeoxyglucose avid
thyroid nodule by positron emission tomography (PET)
scan. Three of these four were confirmed to be malig-
nant with EBUS-TBNA. A systematic review from Shie
and coworkers found the prevalence of incidental focal
abnormalities detected by PET in the thyroid gland to be
roughly 1% (571 from 55160 patients) [15]. Of theseaspirations. Representative microphotographs from EBUS procedure:
ntiated adenocarcinoma with papillary features. Immunohistochemistry
cal staining for carcinoembryonic antigen (D), strong diffuse positivivty
w papanicoulau stained smear with clusters of benign follicular cells
consistent with follicular nodule.
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in origin, which suggests that these findings need to be
confirmed by cytology or histology.
Wakeley and Mulvany divided intrathoracic goiters
into three types based on location and extent: “a”, small
substernal extension of a mainly cervical thyroid goiter;
“b”, partial intrathoracic goiter wherein the major por-
tion of the goiter is situated within the thorax; and “c”,
complete intrathoracic goiter wherein the goiter lies
entirely within the thoracic cavity [16,17]. Following this
classification, in our small series, 5 patients were type
“a”, 2 patients were type “b”, and 5 type “c”.
Ultrasound guided-FNA complications are typically
minor and self-limited such as local pain and small he-
matomas. More severe complications occur in less than
5% of cases: large hematoma, infection, needle track
seeding of malignancy, recurrent laryngeal nerve palsy
[2]. EBUS-TBNA has also been demonstrated to be an
extremely safe procedure with an overall complication
rate of less than 2% [8]. Data on patients undergoing
EBUS-TBNA in the American College of Chest Physi-
cians Quality Improvement Registry, Evaluation and
Education (AQuIRE) database found that out of 1,317
patients at six hospitals, complications occurred in 19
patients only. There were no infectious complications,
and pneumothorax, which occurred in 7 patients, was in
fact associated with the addition of transbronchial lung
biopsy [8]. Of note, there has been a recent report of an
EBUS-TBNA biopsy of a cystic thyroid nodule which re-
sulted in a thyroid abscess [18]. Unlike US-FNA, a com-
pletely aseptic technique, EBUS- TBNA implies passing
the needle through the working channel of the broncho-
scope that might be contaminated with oropharyngeal
flora and/or tracheobronchial secretions. Physicians
should be aware of this potential risk of infection, and
cystic lesions in particular should be avoided.
Conclusions
To the best of our knowledge, this is the first series to de-
scribe the use of EBUS-TBNA for the sampling of thyroid
lesions. In patients with intrathoracic thyroid lesions,
EBUS-TBNA could potentially prevent complications
associated with more invasive procedures, or reduce cost
and anxiety associated with close follow-up and repeat
imaging. We hope our results will prompt prospective
comparisons between EBUS-TBNA, US-FNA and surgi-
cal approach to thoroughly assess its yield and safety
profile. Until then, EBUS-TBNA should be reserved for
intrathoracic thyroid lesions that are not amenable for
US-FNA.
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